Dietary reference intakes for Japanese 2010: Water-soluble vitamins

Journal of Nutritional Science and Vitaminology

Volumn 59, Issue SUPPL., 2013, Pages

  Shibata, Katsumi ^a   Fukuwatari, Tsutomu ^a   Imai, Eri ^b   Hayakawa, Takashi ^c   Watanabe, Fumio ^d   Takimoto, Hidemi ^b   Watanabe, Toshiaki ^e   Umegaki, Keizo ^b  

^a UNIVERSITY OF SHIGA PREFECTURE   (Japan)

^b NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^c GIFU UNIVERSITY   (Japan)

^d TOTTORI UNIVERSITY   (Japan)

^e UNIVERSITY OF HYOGO   (Japan)

Author keywords

Blood; DRI; Requirement; Urine; Water soluble vitamins

Indexed keywords

ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; FOLIC ACID; IMMUNOGLOBULIN; N METHYLNICOTINAMIDE; NICOTINAMIDE; NICOTINIC ACID; PANTOTHENIC ACID; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TRYPTOPHAN; VITAMIN;

ABDOMINAL PAIN; ABSENCE OF SIDE EFFECTS; ABSORPTION; APPETITE DISORDER; ARTICLE; BREAST MILK; CARPAL TUNNEL SYNDROME; CONSTIPATION; CONTACT DERMATITIS; CYANOCOBALAMIN DEFICIENCY; DIARRHEA; DIETARY REFERENCE INTAKE; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG MEGADOSE; DRUG WITHDRAWAL; DYSPEPSIA; ENERGY METABOLISM; FOLIC ACID DEFICIENCY; GASTROINTESTINAL DISEASE; GENETIC POLYMORPHISM; HEADACHE; HEPATITIS; HUMAN; HYPERCHOLESTEROLEMIA; INBORN ERROR OF METABOLISM; INSOMNIA; INSULIN DEPENDENT DIABETES MELLITUS; IRRITABILITY; JAPAN; KIDNEY DYSFUNCTION; LACTATION; LIVER DYSFUNCTION; LIVER TOXICITY; MACROCYTIC ANEMIA; MICROCYTIC ANEMIA; NAUSEA; NEPHROLITHIASIS; NEURAL TUBE DEFECT; NONHUMAN; NUTRITIONAL REQUIREMENT; PERNICIOUS ANEMIA; PRURITUS; PYRIDOXINE DEFICIENCY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RIBOFLAVIN DEFICIENCY; RISK FACTOR; SEBORRHEIC DERMATITIS; SENSORY NEUROPATHY; SIDE EFFECT; SINGLE DRUG DOSE; SKIN REDNESS; THIAMINE DEFICIENCY; TOXICITY; URINARY EXCRETION; WEAKNESS;

EID: 84877683913     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.59.S67     Document Type: Article

References (114)

1. Fukuwatari T, Shibata K. 2008. Relative availability of B-group vitamins in a test diet to free vitamins. Nippon Kaseigaku Zassi (J Home Economic Jpn) 59: 403-410
2. Fukuwatari T, Shibata T. 2009. Relative availability of water-soluble vitamins in a white bread diet to free vitamin. Nippon Kaseigaku Zassi (J Home Economic Jpn) 60: 57-63
3. FAO/WHO. 1967. WHO Technical Report Series No. 362. FAO Nutrition Meeting Report Series No. 41. Requirements of vitamin A, thiamine, ribofavin and niacin. Reports of a Joint FAO/WHO Expert Group. Rome, 6-17 September 1965. p 30-38. Geneva.
4. Idota T, Sugawara M, Yakabe T, Sato N, Maeda T. 1996. The latest survey for the composition of human milk obtained from Japanese mothers. Part X. Content of water-soluble vitamins. Nippon Shôni Eiyô Shôkaki-byô Gakkai Zassi (Jpn J Pediatric Gastroenterol Nutr) 10: 11-20
5. Sakurai T, Furukawa M, Asoh M, Kanno T, Kojima T, Yonekubo A. 2005. Fat-soluble and water-soluble vitamin contents of breast milk from Japanese women. J Nutr Sci Vitaminol 51: 239-247.
6. Shibata K, Endo M, Yamauchi M, Hirose J, Fukuwa-tari T. 2009. Distribution of the water-soluble vitamin content of Japanese breast milk. Nippon Eiyô Shokuryô Gakkaishi (J Jpn Soc Nutr Food Sci) 62: 179-184
7. Suzuki K, Sasaki S, Shinzawa K, Totani M. 2004. Milk intake by breast-fed infants before weaning. Eiyô-gaku Zasshi (Jpn J Nutr Diet) 62: 369-372
8. Hirose J, Endo M, Nagao S, Mizushima K, Narita H, Shibata K. 2008. Amount of breast milk sucked by Japanese breast feeding infants. Nippon Bonyu-Hoiku-gaku Zassi (J Jpn Soc Breastfeeding Res) 2: 23-28
9. Iber FL, Blass J P, Brin M, Leevy CM. 1982. Thiamin in the elderly-relation to alcoholism and to neurological degenerative disease. Am J Clin Nutr 36: 1067-1082.
10. Mills CA. 1941. Thiamine overdosage and toxicity. J Am Med Assoc 116: 2101.
11. Merrill AH, Lambeth JD, Edmondson DE, McCormick DB. 1981. Formation and mode of action of favopro-teins. Annu Rev Nutr 1: 281-317.
12. Innis WS, McCormick DB, Merrill AH,. 1985. Variations in riboflavin binding by human plasma: identification of immunoglobulins as the major proteins responsible. Biochem Med 34: 151-165.
13. Horwitt MK, Harvey CC, Hills OW, Liebert E. 1950. Correlation of urinary excretion of ribofavin with dietary intake and symptoms of ariboflavinosis. J Nutr 41: 247-264.
14. Davis M, Oldham H, Roberts L. 1946. Ribofavin excretions of young women on diets containing varying levels of the B vitamins. J Nutr 32: 143-161.
15. Schoenen JLM, Bastings E. 1994. High-dose ribofavin as a prophylactic treatment of migraine: results of an open pilot study. Cephalalgia 14: 328-329.
16. Zempleni J, Galloway JR, McCormick DB. 1996. Phar-macokinetics of orally and intravenously administered ribofavin in healthy humans. Am J Clin Nutr 63: 54-66.
17. Stripp B. 1965. Intestinal absorption of ribofavin by man. Acta Pharmacol Toxicol (Copenh) 22: 353-362.
18. Ministry of Education, Culture, Sports, Science and Technology, Japan. 2005. Standard Tables of Food Composition in Japan, Fifth revised and enlargement ed, 2004. Tokyo
19. Carter EG, Carpenter KJ. 1982. The bioavailability for humans of bound niacin from wheat bran. Am J Clin Nutr 36: 855-861.
20. Horwitt MK, Harper AE, Henderson LM. 1981. Niacin-tryptophan relationships for evaluating niacin equivalents. Am J Clin Nutr 34: 423-427.
21. Fukuwatari T, Ohta M, Kimtjra N, Sasaki R, Shibata K. 2004. Conversion ratio of tryptophan to niacin in Japanese women fed a purified diet conforming to the Japanese Dietary Reference Intakes. J Nutr Sci Vitaminol 50: 385-391.
22. Goldsmith G, Sarett H, Register U, Gibbens J. 1952. Studies of niacin requirement in man. I. Experimental pellagra in subjects on corn diets low in niacin and tryptophan. J Clin Invest 31: 533-542.
23. Goldsmith G, Rosenthal H, Gibbens J, Unglaub W. 1955. Studies of niacin requirement in man. II. Requirement on wheat and corn diets low in tryptophan. J Nutr 56: 371-386.
24. Horwitt M, Harvey C, Rothwell W, Cutler J, Haffron D. 1956. Tryptophan-niacin relationships in man: Studies with diets deficient in ribofavin and niacin, together with observations on the excretion of nitrogen and nia-cin metabolites. J Nutr 60: 1-43.
25. Jacob RA, Swendseid ME, McKee RW, Fu CS, Clemens RA. 1989. Biochemical markers for assessment of nia-cin status in young men: urinary and blood levels of niacin metabolites. J Nutr 119: 591-598.
26. Fukuwatari T, Murakami M, Ohta M, Kimura N, Jin-No Y, Sasaki R, Shibata K. 2004. Changes in the urinary excretion of the metabolites of the tryptophan-niacin pathway during pregnancy in Japanese women and rats. J Nutr Sci Vitaminol 50: 392-398.
27. Winter SL, Boyer JL. 1973. Hepatic toxicity from large doses of vitamin B3 (nicotinamide). N Engl J Med 289: 1180-1182.
28. Rader JI, Calvert RJ, Hathcock JN. 1992. Hepatic toxicity of unmodified and time-release preparations of nia-cin. Am J Med 92: 77-81.
29. McKenney JM, Proctor JD, Harris S, Chinchili VM. 1994. A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholes-terolemic patients. JAMA 271: 672-677.
30. Pozzilli P, Visalli N, Signore A, Baroni MG, Buzzetti R, Cavallo MG, Boccuni ML, Fava D, Gragnoli C, Andreani D, Lucentini L, Matteoli MC, Crinò A, Cicconetti CA, Teodonio C, Paci E, Amoretti R, Pisano L, Pennafna MG, Santopadre G, Marozzi G, Multari G, Suppa MA, Campea L, De Mattia GC, Cassone Faldetta M, Marietti G, Perrone F, Greco AV, Ghirlanda, G. 1995. Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study). Diabetologia 38: 848-852.
31. Gregory JF. 1997. Bioavailability of vitamin B-6. Eur J Clin Nutr 51 (Suppl 1): S43-48.
32. Tarr JB, Tamura T, Stokstad EL. 1981. Availability of vitamin B6 and pantothenate in an average American diet in man. Am J Clin Nutr 34: 1328-1337.
33. Lui A, Lumeng L, Aronoff GR, Li TK. 1985. Relationship between body store of vitamin B6 and plasma pyridoxal-P clearance: metabolic balance studies in humans. J Lab Clin Med 106: 491-497.
34. Kretsch MJ, Sauberlich HE, Newbrun E. 1991. Electro-encephalographic changes and periodontal status during short-term vitamin B-6 depletion of young, non-pregnant women. Am J Clin Nutr 53: 1266-1274.
35. Leklem JE. 1990. Vitamin B-6: a status report. J Nutr 120 (Suppl 11): 1503-1507.
36. Food and Nutritional Board, Institute of Medicine. 1998. Vitamin B6. In: Dietary Reference Intake, p 150-195. National Academy Press, Washington DC.
37. Isa Y, Kaitou A, Hayakawa T, Sasaki S, Shinzawa K, Suzuki K, Totani M, Tsuge H. 2004. The vitamin B6 content in milk of Japanese women. Vitamins 78: 437-440
38. Reinken L, Dapunt O. 1978. Vitamin B6 nutriture during pregnancy. Int J Vitam Nutr Res 48: 341-347.
39. Schaumburg H, Kaplan J, Windebank A, Vick N, Rasmus S, Pleasure D, Brown MJ. 1983. Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome. N Engl J Med 309: 445-448.
40. Del TA, Bernstein A, Chinn K. 1985. Carpal tunnel syndrome and vitamin B6 therapy. In: Vitamin B6: Its Role in Health and Disease. Current Topics in Nutrition and Disease (Reynolds RD, Leklem JE, eds). Alan R Liss, New York.
41. Watanabe F. 2007. Vitamin B12 sources and bioavail-ability. Exp Biol Med (Maywood) 232: 1266-1274.
42. Food and Nutrition Board, Institute of Medicine. 1998. The B vitamins and choline: overview and methods. In: Dietary Reference Intakes: For Thiamin, Ribofavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline, p 306-356. National Academy Press, Washington DC.
43. Scott JM. 1997. Bioavailability of vitamin B12. Eur J Clin Nutr 51: S49-53.
44. El Kholty S, Gueant JL, Bressler L, Djalali M, Boissel P, Gerard P, Nicolas J P. 1991. Portal and biliary phases of enterohepatic circulation of corrinoids in humans. Gastroenterology 101: 1399-1408.
45. Darby WJ, Bridgforth EB, Le Brocquy J, Clark SL, De Oliveira JD, Kevany J, McGanity WJ, Perez C. 1958. Vitamin B12 requirement of adult man. Am J Med 25: 726-732.
46. Bastrup-Madsen P, Helleberg-Rasmussen I, Norregaard S, Halver B, Hansen T. 1983. Long term therapy of pernicious anaemia with the depot cobalamin preparation betolvex. Scand J Haematol 31: 57-62.
47. Watanabe T, Taniguchi A, Shoji K, Inakuma T, Fukui T, Watanabe F, Miyamoto E, Hashizume N, Sasaki A, Totani M, Nishimuta M, Shibata K. 2005. The concentrations of water-soluble vitamins in breast milk of Japanese women. Vitamins 79: 573-581
48. Loria A, Vaz-Pinto A, Arroyo P, Ramirez-Mateos C, Sanchez-Medal L. 1977. Nutritional anemia. VI. Fetal hepatic storage of metabolites in the second half of pregnancy. J Pediatr 91: 569-573.
49. Vaz Pinto A, Torras V, Sandoval JF, Dillman E, Mateos CR, Cordova MS. 1975. Folic acid and vitamin B12 determination in fetal liver. Am J Clin Nutr 28: 1085-1086.
50. Berlin H, Berlin R, Brante G. 1968. Oral treatment of pernicious anemia with high doses of vitamin B12 without intrinsic factor. Acta Med Scand 184: 247-258.
51. Mangiarotti G, Canavese C, Salomone M, Thea A, Pac-itti A, Gaido M, Calitri V, Pelizza D, Canavero W, Vercel-lone A. 1986. Hypervitaminosis B12 in maintenance hemodialysis patients receiving massive supplementation of vitamin B12. Int J Artif Organs 9: 417-420.
52. Gregory JF. 1989. Chemical and nutritional aspects of foliate research: analytical procedures, methods of folate synthesis, stability, and bioavailability of dietary folates. Adv Food Nutr Res 33: 1-101.
53. Konings EJ, Troost FJ, Castenmiller JJ, Roomans HH, Van Den Brandt PA, Saris WH. 2002. Intestinal absorption of different types of folate in healthy subjects with an ileostomy. Br J Nutr 88: 235-242.
54. Sauberlich HE, Kretsch MJ, Skala JH, Johnson HL, Taylor PC. 1987. Folate requirement and metabolism in nonpregnant women. Am J Clin Nutr 46: 1016-1028.
55. Tamura T, Stokstad EL. 1973. The availability of food folate in man. Br J Haematol 25: 513-532.
56. O'Keefe CA, Bailey LB, Thomas EA, Hofer SA, Davis BA, Cerda JJ, Gregory JF. 1995. Controlled dietary folate affects folate status in nonpregnant women. J Nutr 125: 2717-2725.
57. Milne DB, Johnson LK, Mahalko JR, Sandstead HH. 1983. Folate status of adult males living in a metabolic unit: possible relationships with iron nutriture. Am J Clin Nutr 37: 768-773.
58. Cuskelly GJ, McNulty H, Scott JM. 1996. Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects. Lancet 347: 657-659.
59. Brouwer IA, van Dusseldorp M, West CE, Meyboom S, Thomas CM, Duran M, van het Hof KH, Eskes TK, Hautvast JG, Steegers-Theunissen RP 1999. Dietary folate from vegetables and citrus fruit decreases plasma homocysteine concentrations in humans in a dietary controlled trial. J Nutr 129: 1135-1139.
60. Wolfe JM, Bailey LB, Herrlinger-Garcia K, Theriaque DW, Gregory JF, Kauwell GP. 2003. Folate catabo-lite excretion is responsive to changes in dietary folate intake in elderly women. Am J Clin Nutr 77: 919-923.
61. McPartlin J, Halligan A, Scott JM, Darling M, Weir DG. 1993. Accelerated folate breakdown in pregnancy. Lancet 341: 148-149.
62. Chanarin I, Rothman D, Ward A, Perry J. 1968. Folate status and requirement in pregnancy. Br Med J 2: 390-394.
63. Daly S, Mills JL, Molloy AM, Conley M, Lee YJ, Kirke PN, Weir DG, Scott JM. 1997. Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet 350: 1666-1669.
64. Smith AD. 2007. Folic acid fortification: the good, the bad, and the puzzle of vitamin B-12. Am J Clin Nutr 85: 3-5.
65. Allegra CJ, Drake JC, Jolivet J, Chabner BA. 1985. Inhibition of phosphoribosylaminoimidazolecarbox-amide transformylase by methotrexate and dihydro-folic acid polyglutamates. Proc Natl Acad Sci USA 82: 4881-4885.
66. Matthews RG, Baugh CM. 1980. Interactions of pig liver methylenetetrahydrofolate reductase with methy-lenetetrahydropteroylpolyglutamate substrates and with dihydropteroylpolyglutamate inhibitors. Biochemistry 19: 2040-2045.
67. Dolnick BJ, Cheng YC. 1978. Human thymidylate syn-thetase. II. Derivatives of pteroylmono- and -polyglu-tamates as substrates and inhibitors. J Biol Chem 253: 3563-3567.
68. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, Mulinare J, Zhao P, Wong LY, Gindler J, Hong SX, Cor-rea A. 1999. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 341: 1485-1490.
69. Mulinare J, Cordero JF, Erickson JD, Berry RJ. 1988. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 260: 3141-3145.
70. Milunsky A, Jick H, Jick SS, Bruell CL, MacLaughlin DS, Rothman KJ, Willett W. 1989. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 262: 2847-2852.
71. Laurence KM, James N, Miller MH, Tennant GB, Campbell H. 1981. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J (Clin Res Ed) 282: 1509-1511.
72. Smithells RW, Nevin NC, Seller MJ, Sheppard S, Harris R, Read A P, Fielding DW, Walker S, Schorah CJ, Wild J. 1983. Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 1: 1027-1031.
73. Vergel RG, Sanchez LR, Heredero BL, Rodriguez PL, Martinez AJ. 1990. Primary prevention of neural tube defects with folic acid supplementation: Cuban experience. Prenat Diagn 10: 149-152.
74. Czeizel AE, Dudas I. 1992. Prevention of the frst occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327: 1832-1835.
75. Akar N, Akar E, Deda G, Arsan S. 2000. Spina bifda and common mutations at the homocysteine metabolism pathway. Clin Genet 57: 230-231.
76. Botto LD, Yang Q. 2000. 5,10-Methylenetetrahydrofo-late reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151: 862-877.
77. Cunha AL, Hirata MH, Kim CA, Guerra-Shinohara EM, Nonoyama K, Hirata RD. 2002. Metabolic effects of C677T and A1298C mutations at the MTHFR gene in Brazilian children with neural tube defects. Clin Chim Acta 318: 139-143.
78. de Franchis R, Buoninconti A, Mandato C, Pepe A, Spe-randeo M P, Del Gado R, Capra V, Salvaggio E, Andria G, Mastroiacovo P. 1998. The C677T mutation of the 5,10-methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifda in Italy. J Med Genet 35: 1009-1013.
79. De Marco P, Calevo MG, Moroni A, Arata L, Merello E, Cama A, Finnell RH, Andreussi L, Capra V. 2001. Polymorphisms in genes involved in folate metabolism as risk factors for NTDs. Eur J Pediatr Surg 11(Suppl 1): S14-17.
80. Martinez de Villarreal LE, Delgado-Enciso I, Valdez-Leal R, Ortiz-Lopez R, Rojas-Martinez A, Limon-Benavides C, Sanchez-Pena MA, Ancer-Rodriguez J, Barrera-Saldana HA, Villarreal-Perez JZ. 2001. Folate levels and N(5),N(10)-methylenetetrahydrofolate reductase genotype (MTHFR) in mothers of offspring with neural tube defects: a case-control study. Arch Med Res 32: 277-282.
81. van Rooij IA, Ocke MC, Straatman H, Zielhuis GA, Merkus HM, Steegers-Theunissen RP. 2004. Pericon-ceptional folate intake by supplement and food reduces the risk of nonsyndromic cleft lip with or without cleft palate. Prev Med 39: 689-694.
82. Shaw GM, Rozen R, Finnell RH, Todoroff K, Lammer EJ. 1998. Infant C677T mutation in MTHFR, maternal periconceptional vitamin use, and cleft lip. Am J Med Genet 80: 196-198.
83. Junker R, Kotthoff S, Vielhaber H, Halimeh S, Kosch A, Koch HG, Kassenbohmer R, Heineking B, Nowak-Gottl U. 2001. Infant methylenetetrahydrofolate reductase 677TT genotype is a risk factor for congenital heart disease. Cardiovasc Res 51: 251-254.
84. Voutilainen S, Rissanen TH, Virtanen J, Lakka TA, Salonen JT. 2001. Low dietary folate intake is associated with an excess incidence of acute coronary events: The Kuopio Ischemic Heart Disease Risk Factor Study. Circulation 103: 2674-2680.
85. Ishihara J, Iso H, Inoue M, Iwasaki M, Okada K, Kita Y, Kokubo Y, Okayama A, Tsugane S. 2008. Intake of folate, vitamin B6 and vitamin B12 and the risk of CHD: the Japan Public Health Center-Based Prospective Study Cohort I. J Am Coll Nutr 27: 127-136.
86. Weng LC, Yeh WT, Bai CH, Chen HJ, Chuang SY, Chang HY, Lin BF, Chen KJ, Pan WH. 2008. Is ischemic stroke risk related to folate status or other nutrients correlated with folate intake? Stroke 39: 3152-3158.
87. Wang X, Qin X, Demirtas H, Li J, Mao G, Huo Y, Sun N, Liu L, Xu X. 2007. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet 369: 1876-1882.
88. Toole JF, Malinow MR, Chambless LE, Spence JD, Pet-tigrew LC, Howard VJ, Sides EG, Wang CH, Stampfer M. 2004. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocar-dial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 291: 565-575.
89. Ministry of Health, Labour and Welfare, Japan. 2007. National Health and Nutrition Survey Japan (2005). Tokyo
90. Ministry of Health, Labour and Welfare, Japan. 2008. National Health and Nutrition Survey Japan (2006). Tokyo
91. Kimura N, Fukuwatari T, Sasaki R, Hayakawa F, Shi-bata K. 2003. Vitamin intake in Japanese women college students. J Nutr Sci Vitaminol 49: 149-155.
92. Haslam RH, Dalby JT, Rademaker AW. 1984. Effects of megavitamin therapy on children with attention deficit disorders. Pediatrics 74: 103-111.
93. Iyenga G V, Wolfe WR, Tanner JT, Morris ER. 2000. Content of minor and trace elements, and organic nutrients in representative mixed total diet composites from the USA. Sci Total Environ 256: 215-226.
94. Saitoh Y, Ushio F. 2004. Estimate of the daily dietary intake of biotin, vitamin B6 and niacin from the 1999 Tokyo total diet study. Eiyô-gaku Zasshi (Jpn J Nutr Diet) 62: 165-169
95. Watanabe T, Taniguchi A. 2006. Study on the estimate of dietary intake of biotin by total diet study. Nippon Rinsho Eiyô-Gakkai Zasshi (J Jpn Soc Clin Nutr) 27: 304- 312
96. Murakami T, Yamano T, Nakama A, Mori Y. 2008. Estimation of dietary intake of biotin and its measurement uncertainty using total diet samples in Osaka, Japan. J AOAC Int 91: 1402-1408.
97. Watanabe T, Taniguchi A. 2009. Estimation of dietary intake of biotin from the Japanese diet. Vitamins 83: 461-468
98. Hirano M, Honma K, Daimatsu T, Hayakawa K, Oizumi J, Zaima K, Kanke Y. 1992. Longitudinal variations of biotin content in human milk. Int J Vitam Nutr Res 62: 281-282.
99. Mock DM, Quirk JG, Mock NI. 2002. Marginal biotin deficiency during normal pregnancy. Am J Clin Nutr 75: 295-299.
100. Roth KS, Yang W, Foremann JW, Rothman R, Segal S. 1980. Holocarboxylase synthetase defciency: a biotin-responsive organic acidemia. J Pediatr 96: 845-849.
101. Tsujimura M, Higasa S, Aono K, Seki T. 2006. Vitamin C activity of l-dehydroascorbic acid in human: time-dependent vitamin C urinary excretion after the oral load. Vitamins 80: 281-285
102. Hodges RE, Hood J, Canham JE, Sauberlich HE, Baker EM. 1971. Clinical manifestations of ascorbic acid deficiency in man. Am J Clin Nutr 24: 432-443.
103. Gey K. 1998. Vitamins E plus C and interacting conu-trients required for optimal health. A critical and constructive review of epidemiology and supplementation data regarding cardiovascular disease and cancer. Bio-factors 7: 113-174.
104. Levine M, Rumsey SC, Daruwala R, Park JB, Wang Y. 1999. Criteria and recommendations for vitamin C intake. JAMA 281: 1415-1423.
105. Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, Park JB, Lazarev A, Graum-lich JF, King J, Cantilena LR. 1996. Vitamin C pharma-cokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci USA 93: 3704-3709.
106. Levine M, Wang Y, Paaatty SJ, Morrow J. 2001. A new recommended dietary allowance of vitamin C for healthy young women. Proc Natl Acad Sci USA 98: 9842-9846.
107. Brubacher D, Moser U, Jordan P. 2000. Vitamin C concentrations in plasma as a function of intake: a meta-analysis. Int J Vit Nutr Res 70: 226-237.
108. Blanchard J, Tozer TN, Rowland M. 1997. Pharmacoki-netic perspectives on megadoses of ascorbic acid. Am J Clin Nutr 66: 1165-1171.
109. Traxer O, Huet B, Poindexter J, Pak CY, Pearle MS. 2003. Effect of ascorbic acid consumption on urinary stone risk factors. J Urol 170: 397-401.
110. Massey LK, Liebman M, Kynast-Gales SA. 2005. Ascor-bate increases human oxaluria and kidney stone risk. J Nutr 135: 1673-1677.
111. Cameron E, Campbell A. 1974. The orthomolecu-lar treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer. Chem Biol Interact 9: 285-315.
112. Kallner AB, Hartmann D, Hornig DH. 1981. On the requirements of ascorbic acid in man: steady-state turnover and body pool in smokers. Am J Clin Nutr 34: 1347-1355.
113. Tribble DL, Giuliano LJ, Fortmann SP. 1993. Reduced plasma ascorbic acid concentrations in nonsmokers regularly exposed to environmental tobacco smoke. Am J Clin Nutr 58: 886-890.
114. Preston AM, Rodriguez C, Rivera CE, Sahai H. 2003. Influence of environmental tobacco smoke on vitamin C status in children. Am J Clin Nutr 77: 167-172.